Immune checkpoint inhibitors in SARS-CoV-2 infected cancer patients: the spark that ignites the fire?

por Di Noia, Vincenzo, D’Aveni, Alessandro, Squadroni, Michela, Beretta, Giordano Domenico, Ceresoli, Giovanni Luca
Publicado 2020

Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients

por Canziani, Lorenzo M., Trovati, Serena, Brunetta, Enrico, Testa, Amidio, De Santis, Maria, Bombardieri, Emilio, Guidelli, Giacomo, Albano, Giovanni, Folci, Marco, Squadroni, Michela, Beretta, Giordano D., Ciccarelli, Michele, Castoldi, Massimo, Lleo, Ana, Aghemo, Alessio, Vernile, Laura, Malesci, Alberto, Omodei, Paolo, Angelini, Claudio, Badalamenti, Salvatore, Cecconi, Maurizio, Cremonesi, Alberto, Selmi, Carlo
Publicado 2020